Firm at a glance
Mekong Capital is a platform private equity firm founded in 2001 and headquartered in Ho Chi Minh City, Vietnam, per its own website [S1].
What they buy
The firm’s portfolio reflects a concentration in Vietnamese consumer, healthcare, and biotechnology businesses [S1]. Observed investments span financial services, retail pharmacy, genetic testing, probiotics, mattress retail, and agricultural biotechnology [S1]. The firm maintains offices in both Ho Chi Minh City and Hanoi [S1], suggesting a focus on domestic Vietnamese opportunities across multiple sectors.
Portfolio
Healthcare and Biotechnology
Pharmacity operates in healthcare retail [S1]. Gene Solutions focuses on healthcare and biotechnology [S1], acquired in January 2025 [S2]. LiveSpo operates in the biotechnology sector [S1]. Entobel works in biotechnology and agricultural technology [S1].
Consumer and Retail
Vua Nem operates in consumer retail [S1]. Marou, a consumer business acquired in 2011 [S1], represents one of the firm’s earlier investments.
Financial Services
F88 operates in financial services [S1].
Recent activity (last 24 months)
* Gene Solutions, a healthcare and biotechnology company, acquired January 2025 [S2]
* HUSK acquired May 2024 [S2]
How this firm fits a seller
Mekong Capital appears positioned for owner-operators of Vietnamese businesses in consumer, healthcare, and biotechnology sectors based on its observed portfolio composition [S1]. The firm’s dual-office presence in Vietnam’s two largest cities [S1] suggests operational familiarity with local market dynamics. Recent transaction activity through early 2025 [S2] indicates continued investment appetite. For sellers in healthcare services, biotechnology, or consumer retail with Vietnamese operations, the firm’s sector history and geographic focus may represent a natural fit.
Sources
[S1] https://www.mekongcapital.com (as of 2025-01-15)
[S2] https://www.mekongcapital.com/communications/news/ (as of 2025-01-15)
Frequently asked questions
Does Mekong Capital buy healthcare businesses?
Yes, healthcare represents a significant portion of the firm’s observed portfolio per public sources [S1]. The firm has invested in Pharmacity (healthcare retail), Gene Solutions (healthcare and biotechnology, acquired January 2025), and LiveSpo (biotechnology) [S1][S2]. These investments suggest active interest in Vietnamese healthcare and related life sciences businesses.
What companies has Mekong Capital acquired recently?
The firm acquired Gene Solutions, a healthcare and biotechnology company, in January 2025 [S2]. In May 2024, Mekong Capital acquired HUSK [S2]. Earlier portfolio companies include F88 (financial services), Pharmacity (healthcare retail), and Vua Nem (consumer retail) [S1].
Where is Mekong Capital based and how big is the firm?
Mekong Capital is headquartered in Ho Chi Minh City, Vietnam, with an additional office in Hanoi [S1]. The firm was founded in 2001 [S1]. Fund size and assets under management were not publicly disclosed in available sources as of January 2025.
Is Mekong Capital still actively acquiring?
Yes, the firm completed an acquisition of Gene Solutions in January 2025 [S2], indicating current investment activity. The firm also acquired HUSK in May 2024 [S2], demonstrating consistent transaction activity over the trailing twelve months.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.